Risk factor, monitoring, and treatment for snakebite induced coagulopathy: a multicenter retrospective study

Yong Jun Jeon1, Jong Wan Kim2, SungGil Park2

  • 1Department of Surgery, Chinjujeil Hospital, Jinju, Korea.

Acute and Critical Care
|November 20, 2019
PubMed

Insights

Lower cholesterol levels may indicate a higher risk of disseminated intravascular coagulation (DIC) after snakebite. Coagulopathy monitoring is essential for 4-5 days post-bite, as standard treatments may not benefit patients without bleeding.

Area of Science:

  • Toxicology
  • Hematology
  • Clinical Medicine

Background:

  • Snakebite envenomation can lead to coagulopathy, a complication distinct from disseminated intravascular coagulation (DIC) from other causes.
  • The optimal treatment for snakebite-associated coagulopathy remains a subject of debate.

Purpose of the Study:

  • To investigate the clinical features and outcomes of snakebite-associated coagulopathy.
  • To identify risk factors for overt DIC following snakebite.
  • To evaluate the effectiveness of current treatment strategies.

Main Methods:

  • Retrospective review of medical records for patients hospitalized due to snakebite between January 2006 and September 2018.
  • Analysis of patient demographics, clinical presentations, laboratory results, and treatment interventions.
  • Application of the International Society of Thrombosis and Hemostasis scoring system to diagnose overt DIC.

Main Results:

  • Of 226 hospitalized patients, 21 developed overt DIC. Initial low cholesterol levels were associated with overt DIC development.
  • Prolonged International Normalized Ratio (INR) was observed up to 4-5 days post-bite.
  • High-dose antivenom and blood product transfusions (fresh frozen plasma, cryoprecipitate) did not shorten INR duration or hospital stay in non-bleeding DIC patients.

Conclusions:

  • Low initial cholesterol may be a risk factor for overt DIC post-snakebite.
  • Continuous coagulopathy assessment for at least 4-5 days is crucial, even in asymptomatic patients.
  • Aggressive antivenom and transfusion strategies may not be beneficial for coagulopathic patients without active bleeding.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
245
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
166
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
229
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
252
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
254